Rare diseases
Investigational molecules
Locations
Back to Croatia18 clinical trials in Zadar, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
CroatiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
CroatiaStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
CroatiaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
CroatiaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
CroatiaStudy on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
CroatiaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CroatiaStudy of Plozasiran for Adults with Severe Hypertriglyceridemia
CroatiaStudy on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis
CroatiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
CroatiaCroatiaStudy of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on psoriatic arthritis, systemic sclerosis, and systemic lupus erythematosus. Clinical trials are evaluating new therapeutic approaches including zasocitinib and efgartigimod for improving patient outcomes.
Studies aim to address both skin manifestations and systemic symptoms of these conditions.
Groundbreaking research in multiple sclerosis treatment, testing new therapeutic agents like remibrutinib compared to established treatments. Focus on reducing relapse frequency and improving patient quality of life.
Emphasis on developing more effective treatment options with better tolerability profiles.
Comprehensive studies on Crohn's disease, ulcerative colitis, and celiac disease. Trials evaluating innovative treatments including MORF-057, rosnilimab, and ZED1227 for improving disease management.
Research focuses on both symptom control and mucosal healing.
Advanced research in severe eosinophilic asthma and COPD. Studies evaluating dexpramipexole and CHF6001 DPI as potential treatments for improving respiratory function and reducing exacerbations.
Focus on developing targeted therapies for severe respiratory conditions.
Important studies in atrial fibrillation and hypertriglyceridemia. Clinical trials examining new anticoagulants like milvexian and treatments for metabolic disorders.
Research aims to improve cardiovascular outcomes and prevent complications.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
